This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Sangamo BioSciences Inc (SGMO)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 10.19M 21.68M 16.77M 10.78M
Receivables 3.49M 4.32M 1.25M 703.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 648.00K 499.00K 0.00 0.00
Total Current Assets 97.27M 68.36M 85.69M 61.31M
Property, Plant & Equipment, Gross 4.93M 4.50M 4.33M 3.75M
Accumulated Depreciation & Depletion 3.52M 2.95M 2.73M 2.08M
Property, Plant & Equipment, Net 1.41M 1.54M 1.60M 1.67M
Intangibles 1.87M 0.00 0.00 0.00
Other Non-Current Assets 38.70M 12.62M 41.00K 12.00K
Total Non-Current Assets 43.56M 14.17M 1.64M 1.68M
Liabilities & Shareholder Equity
Total Assets 140.84M 82.53M 87.34M 63.00M
Accounts Payable 3.02M 4.01M 4.11M 5.65M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 396.00K 2.30M 0.00 0.00
Total Current Liabilities 10.13M 8.79M 7.20M 7.09M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 748.00K 0.00 0.00 0.00
Other Non-Current Liabilities 8.25M 8.85M 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 9.00M 8.85M 0.00 0.00
Total Liabilities 19.13M 17.64M 7.20M 7.09M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 121.71M 64.90M 80.13M 55.91M
Common Par 622.00K 531.00K 526.00K 454.00K
Additional Paid In Capital 423.21M 339.85M 332.84M 272.95M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -302.13M -275.51M -253.24M -217.50M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 12.00K 26.00K 12.00K -6.00K
Total Capitalization 121.71M 64.90M 80.13M 55.91M
Total Equity 121.71M 64.90M 80.13M 55.91M
Total Liabilities & Stock Equity 140.84M 82.53M 87.34M 63.00M
Total Common Shares Outstanding 62.24M 53.06M 52.55M 45.38M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 55.97M 52.74M 50.51M 45.17M
Diluted Weighted Shares Outstanding 55.97M 52.74M 50.51M 45.17M
Number of Employees 85 84 83 81
Number of Part-Time Employees 0 0 0 0

SGMO Sangamo BioSciences Inc

Analysts Ratings for SGMO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

SGMO Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs